Biotransformation on nitazoxanide by filamentous fungi - a microbial model to mammalian metabolism
DOI:
https://doi.org/10.22456/2527-2616.145722Keywords:
nitazoxanide, biotransformation, Aspergillus niger, Cunninghamella elegans, metabolitesAbstract
Filamentous fungi exhibit a complex morphology and can display various shapes depending on the species and environment. These characteristics serve as advantages in biotransformation studies by allowing substances to undergo processes that lead to the production of both existing metabolites and new compounds with potential pharmacological activity. In this regard, the biotransformation of drugs using microorganisms emerges as an economical and ecologically viable strategy for modifying the structures of biologically active compounds, studying the metabolism of molecules, and eliminating or reducing their toxicity. Therefore, the objective of this study was to investigate the biotransformation capacity of the drug nitazoxanide by the endophytic fungi Aspergillus niger ATCC 9029 and Cunninghamella elegans ATCC 9245. High-performance liquid chromatography was employed to monitor metabolite formation, while ultra-high-performance liquid chromatography coupled with sequential mass spectrometry (UHPLC-QTOF/MS) was utilized to identify these metabolites. After an incubation period of 240 hours, nitazoxanide was transformed into two metabolites by C. elegans. A. niger demonstrated a consumption rate of 94.17% for nitazoxanide, with two additional metabolites identified. This study highlights the potential of using fungi both as a model for metabolism and as a means of producing metabolites on a larger scale, while also identifying a new and significant area of application for the biotransformation approaches involving filamentous fungi.
Downloads
References
Khan MF, Hof C, Niemcová P, Murphy CD. Recent advances in fungal xenobiotic metabolism: enzymes and applications. World J Microbiol Biotechnol [Internet]. 2023 Nov 2;39(11):296. Available from: https://link.springer.com/10.1007/s11274-023-03737-7 DOI: https://doi.org/10.1007/s11274-023-03737-7
Ibrahim ARS, Mansour MK, Ahmed MMA, Ulber R, Zayed A. Metabolism of natural and synthetic bioactive compounds in Cunninghamella fungi and their applications in drug discovery. Bioorg Chem [Internet]. 2023 Nov 1;140:106801. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0045206823004625 DOI: https://doi.org/10.1016/j.bioorg.2023.106801
Rossingnol JF, Cavier R. Synthesis and antiparasitic activity of 2-benzoamino nitrothiazoles. Chem Abstr. 1975;83:28216.
Broekhuysen J, Stockis A, Lins RL, Graeve J De, Rossignol JF. Nitazoxanide: pharmacokinetics and metabolism in man. Int Journal of Clinical Pharmacology and Therapeutics [Internet]. 2000 Aug 1;38(08):387–94. Available from: http://www.dustri.com/article_response_page.html?artId=6194&doi=10.5414/CPP38387&L=0 DOI: https://doi.org/10.5414/CPP38387
Gekonge B, Bardin MC, Montaner LJ. Short Communication: Nitazoxanide Inhibits HIV Viral Replication in Monocyte-Derived Macrophages. AIDS Res Hum Retroviruses [Internet]. 2015 Feb;31(2):237–41. Available from: http://www.liebertpub.com/doi/10.1089/aid.2014.0015 DOI: https://doi.org/10.1089/aid.2014.0015
Oesch F, Fabian E, Landsiedel R. Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models. Arch Toxicol [Internet]. 2018 Aug 18;92(8):2411–56. Available from: http://link.springer.com/10.1007/s00204-018-2232-x DOI: https://doi.org/10.1007/s00204-018-2232-x
Guo L, Dial S, Shi L, Branham W, Liu J, Fang JL, et al. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metabolism and Disposition. 2011;39(3). DOI: https://doi.org/10.1124/dmd.110.035873
Brandon EFA, Raap CD, Meijerman I, Beijnen JH, Schellens JHM. An update on in vitro test methods in human hepatic drug biotransformation research: Pros and cons. Toxicol Appl Pharmacol. 2003;189(3). DOI: https://doi.org/10.1016/S0041-008X(03)00128-5
Gonçalves MD, Tomiotto-Pellissier F, de Matos RLN, Assolini JP, da Silva Bortoleti BT, Concato VM, et al. Recent Advances in Biotransformation by Cunninghamella Species. Curr Drug Metab. 2021 Nov 26;22(13):1035–64. DOI: https://doi.org/10.2174/1389200222666211126100023
Tembeni B, Idowu OE, Benrkia R, Boutahiri S, Olatunji OJ. Biotransformation of selected secondary metabolites by Alternaria species and the pharmaceutical, food and agricultural application of biotransformation products. Nat Prod Bioprospect. 2024 Dec 19;14(1):46. DOI: https://doi.org/10.1007/s13659-024-00469-5
Lustosa KRMD, Menegatti R, Braga RC, Lião LM, de Oliveira V. Microbial β-glycosylation of entacapone by Cunninghamella echinulata ATCC 9245. J Biosci Bioeng [Internet]. 2012 May;113(5):611–3. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1389172312000254 DOI: https://doi.org/10.1016/j.jbiosc.2012.01.004
Sponchiado R, Sorrentino JM, Olegário N, Oliveira SS, Cordenonsi LM, Silveira GP, et al. Microbial transformation of ambrisentan to its glycosides by Cunninghamella elegans. Biomedical Chromatography [Internet]. 2019 Jun 15;33(6):1–7. Available from: https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bmc.4496 DOI: https://doi.org/10.1002/bmc.4496
Murzyn A, Popiół J, Gunia-Krzyżak A, Żelaszczyk D, Dąbrówka B, Koczurkiewicz-Adamczyk P, et al. Biotransformation of oxybenzone and 3-(4-methylbenzylidene)camphor in Cunninghamella species: Potential for environmental clean-up of widely used sunscreen agents. J Hazard Mater. 2025 Jun;489:137544. DOI: https://doi.org/10.1016/j.jhazmat.2025.137544
Zheng C chao, Gao L, Sun H, Zhao XY, Gao Z qing, Liu J, et al. Advancements in enzymatic reaction-mediated microbial transformation. Heliyon. 2024 Oct;10(19):e38187 DOI: https://doi.org/10.1016/j.heliyon.2024.e38187
Downloads
Published
Versions
- 30-03-2026 (2)
- 18-07-2025 (1)
How to Cite
Issue
Section
License
Copyright (c) 2025 Drug Analytical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Licensing:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.
